RGR — Sturm, Ruger & Company, Inc. · 2026-09-06 · Verdict: WATCH · Conviction 3

Price $38.49 (screen row, universe_under2b.csv built 2026-09-06; no live quote available) · Mkt cap $615M · EV ~$497M · EV/EBIT n/m on CY2025 (EBIT -$12.3M), ~18x annualized H1-2026 adjusted EBIT · FCF yield 6.5% on EV (TTM) · Net cash $117.5M · ADV $4.6M Sources read: 10-K filed 2026-03-02 (Items 1, 1A, 7), 10-Q filed 2026-07-29 (Item 2), DEF 14A filed 2025-04-17, 8-Ks dated 2026-05-06, 2026-05-08, 2026-05-28, 2026-06-04, 2026-07-29, 2026-07-31, Form 4s (12m), Q1 and Q2 2026 call transcripts furnished as EX-99.1.

1. What the business actually does

Ruger designs and manufactures firearms in the United States and sells them to the commercial sporting market through 13 independent wholesale distributors, which take over 90% of sales (10-K 2026-03-02, Item 1A). Roughly 99% of revenue is firearms. The 2025 mix was rifles $338.2M, pistols $141.9M, revolvers $39.2M and accessories $27.4M (10-K, Item 1). Three distributors, Lipsey's, Sports South and Davidson's, were 27%, 22% and 18% of 2025 firearms sales (10-K, Item 1). Manufacturing sits in Newport NH, Prescott AZ, Mayodan NC and, since July 2025, Hebron KY, bought as the Anderson Manufacturing asset purchase for $15.8M (10-K, Item 7).

2. Why it is mispriced — the edge case

The screen-level edge is real but shallow. CY2025 shows an operating loss of $12.3M and a net loss of $4.4M (10-K, Item 7), which makes every trailing multiple meaningless. That loss is almost entirely a $17.0M inventory rationalization write-off plus product rationalization and leadership-transition costs taken in Q2 2025 (10-K, Item 7 EBITDA reconciliation); underneath it, 2025 EBITDA was $29.5M. The screen row is flattering in the other direction: it counts only $30.7M of cash and misses $86.8M of short-term investments, and books CY2025 capex at $15.8M when the 10-K says $30.9M, so true CY2025 free cash flow was about $23.4M, not the $38.5M shown.

The honest conclusion is that little mispricing is left. The stock is only 17% below its 52-week high with positive 12-1 momentum, so the market has already looked through the write-off. What remains is structural under-ownership rather than underpricing: $4.6M of average daily volume, two sell-side analysts on the Q2 call (Lake Street and Aegis), and an industry many institutional mandates exclude. Under-owned is not the same as cheap. Because I cannot name a specific mispricing, the verdict is capped at WATCH.

3. Unit economics and growth

The operating recovery is genuine and measurable. Q2 2026 net sales rose 19% to $158.1M with gross margin of 21.3% against 3.9% a year earlier, and H1 sales rose 12% to $299.4M at a 20.6% gross margin against 13.1% (10-Q, Item 2). Adjusted EBITDA was $16.6M in Q2 (10.5% margin) and $27.5M in H1, against $19.7M in H1 2025 (10-Q, Item 2). Average selling price rose 10% to $384 (Q2 release, 2026-07-29). Estimated distributor sell-through rose 19% in Q2 against a 5% rise in adjusted NICS, and 11% in H1 against 3% (10-Q, Item 2), the strongest evidence in the file that Ruger is taking share rather than riding the cycle. New products were $80.9M or 29% of H1 firearms sales, and unit backlog was 712,700 against 543,900 at year end (10-Q, Item 2).

Two cautions. Backlog ASP fell from $524 to $465 and management says it does not use backlog to plan production (10-Q, Item 2), so it is a weak forward indicator. And H1 2026 adjusted EPS of $0.79 is below H1 2025 adjusted EPS of $0.87 (Q2 release). The recovery is off a written-down base, not yet above the prior year.

4. Balance sheet and capital allocation

Cash and short-term investments were $117.5M at June 27, 2026, current ratio 3.3 to 1, no debt, with a $40M revolver undrawn to January 2028 (10-Q, Item 2). That is $7.35 a share, 19% of market value. TTM operating cash flow is about $64.5M against $32.2M of capex, of which $15.0M was the Anderson closing payment.

Capital allocation has gone quiet. Ruger repurchased $34.4M of stock in 2024 and $26.1M in 2025 at an average of $35.60, but bought nothing in H1 2026 with $14.3M still authorized (10-K, Item 7; 10-Q, Item 2). Shares outstanding fell only 1.1% year over year. Stockholders approved raising authorized shares from 40M to 60M (8-K 2026-05-28, Item 5.03), which is acquisition currency and a dilution channel worth watching. Three insiders bought $288,615 in the open market with no sales, including the CEO at $39.15 and a director at $38.00 (Form 4s, 2026-05-12 to 2026-05-21). Directors and officers held 4.6% as a group (DEF 14A 2025-04-17). The board raised CEO pay in June to $800,000 base, a 100% target bonus and 300% of salary in equity (8-K 2026-06-04), a large step up in a year when adjusted EPS is down.

5. Management: what they said versus what they did

Todd Seyfert took over in March 2025 and has been specific and so far accurate. On the Q1 call he said Beretta-related costs would run off "by the end of May" (Q1 2026 call, CEO); they fell from $3.2M in Q1 to $1.2M in Q2 (10-Q, Item 2). He said Q2 priorities were recovering the Q1 weather-driven shortfall of roughly 30,000 units and rebuilding inventory; Q2 production rose 22% sequentially and finished goods went from 34,700 to 50,600 units (10-Q, Item 2). Capex guidance is the soft spot: the 10-Q says $20M to $30M, the release and both calls say about $30M, and only $8.1M was spent in H1.

6. Valuation

At $38.49 the enterprise is about $497M against TTM revenue of $577M, so 0.86x sales. TTM adjusted EBITDA is roughly $40M, about 12x; annualized H1 adjusted EBIT of about $27M is about 18x. Reverse DCF: at a 10% required return with no growth, the price implies roughly $64M of sustainable pretax EBIT, an operating margin near 10.5% on about $610M of sales, a level Ruger last cleared in 2023 at 9.6% and did not reach in 2024 (5.9%) or 2025 (negative) (10-K, Item 7).

Base (50%): 2027 revenue $610M at an 8% adjusted EBIT margin, $49M at 10x plus $130M net cash, about $39 a share. Bear (30%): NICS rolls over, revenue $520M at 4%, $21M at 8x plus $110M net cash, about $17. Bull (20%): Ruger 2030 works, $680M of revenue at 12% by 2028, $82M at 11x plus $170M net cash, or a Beretta transaction, about $66. Probability weighted, about $38, essentially the price.

7. Catalysts and timeline

Q3 results in late October are the first clean quarter without Beretta or severance costs. The Rights Plan expires October 13, 2026 (10-K, Item 7), after which Beretta's position is unconstrained by it. A resumed buyback would signal management thinks the stock is cheap; the CEO said they would buy "if we feel our stock set at a lower point than we think it's worth" (Q2 2026 call). Deferred product launches land in H2 into the hunting and holiday season.

8. Risks and pre-registered kill criteria

Firearms demand is politically and cyclically driven, over 90% of sales run through 13 distributors, and the company self-insures product liability through a captive formed in September 2024 (10-Q, Item 2). Kill criteria: 1. Estimated distributor sell-through grows slower than adjusted NICS in any quarter. That single number is the whole share-gain thesis. 2. Adjusted EBITDA margin below 8% for two consecutive quarters (10.5% in Q2 2026). 3. Unit backlog falls below 500,000 (712,700 at Q2 2026), which would mean Q1 and Q2 orders were a pull-forward. 4. Net insider selling above $1M, or an equity-funded acquisition using the newly authorized shares that exceeds 10% of shares outstanding.

9. Verdict and one-paragraph summary

WATCH, conviction 3. Ruger is a genuinely improving business at a fair price rather than a mispriced one. The 2025 loss that makes the screen light up was a $17.0M inventory write-off, and the operating recovery under a new CEO is real: five straight quarters of year-over-year sales growth, Q2 sales up 19% with gross margin back to 21.3% from 3.9%, distributor sell-through beating adjusted NICS by 14 points, and $117.5M of net cash with no debt against a $615M market value. But the stock is only 17% off its high, H1 adjusted EPS of $0.79 is still below last year's $0.87, and at $38.49 the price already implies a return to roughly a 10% operating margin that Ruger has not earned since 2023. The buyback has been switched off all year while insiders bought only small amounts personally, which suggests management does not see it as obviously cheap either. Watch the Q3 print, a resumed repurchase, and what Beretta does when the rights plan expires on October 13; a bear-case retest toward the mid-20s would make this an easy IDEA.

Research for discussion, not investment advice. Positions and sizing are the reader's decision.